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Relative roles and functional relationships of resident memory T cells (TRM) and central mem-
ory T cells (TCM) generated in response to skin antigenic challenge
O Gaide,1 X Jiang,1 S Nizza,1 C Desmarais2 and TS Kupper1 1 Dermatology, Brigham and
Women’s, Boston, MA and 2 Adaptive Biotech, Seatlle, WA
We recently demonstrated that skin TRM provide much more rapid and effective anti-viral protec-
tion than do circulating TCM specific for the same infectious antigen. In the present study, we study
non-infectious antigen challenges to further assess the role of these two memory T cell populations.
We demonstrate that chemicals that mediate contact hypersensitivity induces a population of skin
resident TRM that mediate a very rapid recall response. This response is strongest at the site of sen-
sitization, but also occurs at distant skin sites. We used parabiotic mice to further study this phe-
nomenon, and demonstrate that contact sensitizer antigen-specific blood TCM equilibrate between
mice, while skin TRM do not. Using this model, we show that populations of antigen specific skin
TRM and circulating TCM are generated concomitantly during sensitization. We find that skin TRM
mediate rapid (<24h) recall responses, but that in their absence, TCM can infiltrate the skin and
mount a slower immune response (>72 hrs). We next asked whether TRM and TCM can be derived
from the same naïve T cell precursor. Using high throughput TCR sequencing, we assessed the T
cell clonal repertoire response to DNFB, and in parallel to ovalbumin and to modified Vaccinia
Ankara virus, and followed these clones molecularly in normal and parabiotic mouse models. We
find that T cells carrying the identical TCR CDR3 Vb sequence—thus originating from the same naïve
T cell clone—-are found in great abundance not only in skin TRM (sensitized skin > unsensitized
skin) but also in TCM from both draining and distant lymph node. These results indicate that after
skin immunization, a given antigen specific naïve T cell clonally expands to give rise simultane-
ously to TRM and TCM compartments, and that these cells have complementary roles in generat-
ing tissue specific and generalized immunity.
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Regulatory T cells suppress basophils-induced IgE-mediated chronic allergic inflammation
K Sugita,1 Y Minegaki,2 S Nakamizo,2 A Otsuka,2 T Nomura,2 M Nakamura,1 Y Miyachi2 and
K Kabashima2 1 Department of Dermatology, University of Occupational and Environmental
Health, Kitakyushu, Japan and 2 Department of Dermatology, Kyoto University Graduate
School of Medicine, Kyoto, Japan
Regulatory T cells (Tregs) play important roles not only in the maintenance of skin homeostasis but
also in the regulation of immune responses through suppressing the effector T cell functions in the
skin. However, it remains to be clarified whether Tregs are capable of modulating basophil func-
tions. To determine whether Tregs influence basophil functions, we studied IgE-mediated chronic
allergic inflammation induced by the activation of basophils. Here we found that depletion of Tregs
by anti-human CD2 antibody using human CD2/Foxp3 knockin mice exaggerated the IgE-medi-
ated chronic allergic inflammation. We also found that the number of basophils in the skin lesion
was elevated by depletion of Tregs. Consistently, the expression level of mRNA for mcp8, a basophil-
specific differentiation marker, and IL-4 was upregulated by Treg depletion. In addition, bone mar-
row-derived basophils from IL-4/eGFP reporter mice cocultured with Tregs exhibited decreased per-
centage of IL-4/eGFP+ basophils. Notably, adoptive transfer of Tregs normalized the enhanced
basophils-induced IgE-mediated chronic allergic inflammation in RAG-2-deficient mice lacking both
T and B cells or nude mice both in terms of ear swellings and histological features, including
eosinophil and neutrophil infiltration. Thus, Tregs are critical for termination of the basophil-depend-
ent chronic allergic inflammation.
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Dermal dendritic cells initiate the elicitation phase of contact hypersensitivity via immuno-
logical synapse formation
Y Natsuaki,1 G Egawa,1 S Nakamizo,1 H Tanizaki,1 T Hashimoto,2 Y Miyachi1 and K Kabashima1
1 Department of dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
and 2 Department of dermatology, Kurume University School of Medicine, Kurume, Japan
Allergic contact dermatitis is a common skin disease, characterized as a localized rash induced by
contact with a foreign antigen. Contact hypersensitivity (CHS) is a murine contact dermatitis model,
and consists of the sensitization and elicitation phases. Thus far, the roles of cutaneous dendritic
cells (DCs) in the sensitization phase have been extensively studied, however, their roles in the elic-
itation phase remain largely unknown. Initially, we evaluated the antigen presenting capacity of
cutaneous DCs by DC subset-specific depletion system using CD11c-DTR (diphtheria toxin recep-
tor) and Langerin-DTR mice in combination with bone marrow chimeric techniques. Depletion of
LCs alone in the elicitation phase did not change CHS responses 24 h after elicitation, while deple-
tion of dermal DCs alone impaired CHS. These findings suggest that dermal DCs are essential for
the establishment of CHS. Next, we analyzed the dynamics of dermal DCs and memory T cells in
the elicitation phase of CHS using a two-photon microscopy system. We found that dermal DCs
actively migrated and accumulated in perivascular areas of the dermis after elicitation, and dermal
DCs and memory T cells interact for several hours. This interaction was abrogated by anti-LFA-1
neutralizing antibody treatment in vivo in accord with attenuated memory T cell proliferation in
situ and impaired CHS responses. Taken together, our current findings suggest that dermal DCs are
responsible for antigen presentation in the elicitation phase and that memory T cells interact with
DCs for local T cell proliferation and establishment of CHS in an LFA-1 dependent manner, which
is similar to immunological synapse formation in the lymph nodes in the sensitization phase of CHS.
004 
Mast cells establish effective anti-tumor immune defense
S Kaesler, T Volz, M Koeberle, F Woelbing, M Roecken and T Biedermann Dermatology,
Eberhard Karls University, Tuebingen, Germany
Despite detectable tumor-specific T cells in cancer patients immune defense fails to reject the tumors
in most cases. However, in cutaneous melanoma, T cell mediated tumor regression is frequently
observed and we identified high numbers of mast cells (MC) especially within the area of tumor
regression. We hypothesized that accumulated MC otherwise supporting tumor development and
growth may orchestrate cancer defense once activated by the appropriate danger signals. One impor-
tant receptor for danger signals is Toll-like receptor 4 (TLR4) and in vitro TLR4 ligation resulted in
potent activation of human and mouse MC. Consequently, we analyzed a murine model of cuta-
neous melanoma: After one week of tumor growth, when MC are already recruited to the melanomas,
activation of TLR4 significantly enhanced T cell recruitment to the melanomas and tumor defense
in wildtype but not in mast cell deficient sash mice. In this model TLR4 ligands selectively target
MC because reconstitution of TLR4-/- mice with wildtype MC but not with TLR4-/- MC established
effective tumor defense. Searching for underlying mechanisms we identified a selective marked
upregulation and secretion of the chemokine IP-10 (CXCL10) following TLR4 mediated MC activa-
tion. To prove the in vivo relevance of MC-derived IP-10 for effective tumor defense, MC deficient
mice were either reconstituted with wildtype MC or with IP-10-/- MC: Only mice reconstituted
with IP-10 secreting MC upregulated recruitment of tumor-specific T cells and established potent
anti-tumor immune responses upon TLR4 activation confirming the crucial role of MC and MC
derived IP-10. In summary our data demonstrate that activation of MC and MC derived IP-10 can
orchestrate effective tumor defense recruiting T cells and initiating tumor rejection. These data are
very important for the development of future strategies of cancer immunotherapy and highlight a
new role of MC in tumor immunosurveillance.
002 
Complete cutaneous B-cell lymphoma (A20) regression following intratumoral injections of
a novel STAT3-inhibitor (rR9-GRIM19) alone is elicited via rapid CD8+ and CD4+ T cell con-
version of IL-10-producing into IL-17/ IFN-gamma-producing phenotypes
N Shibagaki, F Hanawa and S Shimada Dermatology, University of Yamanashi, Faculty of
Medicine, Chuo-shi, Japan
To inhibit the STAT3-mediated signaling cascade in cancer microenvironment, we generated a fusion
protein, designated rR9-GRIM19, that contained two distinct components—the nona-arginine pro-
tein-transduction domain (R9-PTD), and GRIM-19 protein—because GRIM-19 physically interacts
with STAT3 and R9-PTD are transduced efficiently when injected tumors in vivo. Our previous results
demonstrated that intratumoral (i.t.) injections of rR9-GRIM19 alone elicited complete regression
of established A20 tumor (B-cell lymphoma line with phosphorylated-STAT3; pSTAT3 expression
and IL-10 production, but no IL-6) in mice by eliciting A20-specific CTL activity. Based on these
results, we investigated how immunocompetent cells participated in antitumor effects. Our results
demonstrated that rR9-GRIM19-mediated antitumor effects were not observed in A20-bearing nude
mice, but those were restored simply by the adoptive transfer of normal CD8+ T cells. Although
pSTAT3 expression was elevated in “all” CD8+ and CD4+ T cells in tumor-draining lymph nodes
(DLNs) of untreated A20-bearing mice with IL-10-producing phenotypes, pSTAT3 expression was
completely reverted to basal levels with dramatic conversion into IL-17/ IFN-γ-producing CD8+ and
CD4+ T cell phenotypes after i.t. injections of rR9-GRIM19. We also found that the CD8+ IFN-γ+/
CD8+ IL-10+ ratio, as well as the CD4+ IFN-γ+/ CD4+ IL-10+ ratio, in DLNs was upregulated fol-
lowing i.t. injections of rR9-GRIM19. Interestingly, many CD4+ and FoxP3+ cells infiltrated the A20-
tumor sites in untreated mice. In contrast, RORγt+/ T-bet+ cells infiltrated the A20-tumor sites in
mice treated with i.t. injections of rR9-GRIM19. These results indicated that local administration of
rR9-GRIM19 had some advantages as a novel anti-STAT3 cancer immunotherapy because it strongly
inhibited STAT3-regulated molecules in cancer microenvironment, including IL-10.
006 
Immunostimulatory effects of exosomes from keratinocytes
K Kotzerke,1 T Aung,2 GG Wulf,2 H Urlaub,3 MP Schön,1 M Mempel1 and A Braun1 1 Department
of Dermatology, Venereology, and Allergology, Georg August University, Goettingen,
Germany, 2 Department of Hematology and Oncology, Georg August University, Goettingen,
Germany and 3 Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical
Chemistry, Goettingen, Germany
During inflammation, keratinocytes not only function as mechanical barrier but also influence
immune processes by secretion of soluble factors. Exosomes which are small membrane vesicles of
endocytotic origin are thought to play an important role in intercellular communication. However,
it remains unknown whether keratinocytes produce exosomes as immune modulators. Thus, we
investigated immune effects induced by keratinocytes’ exosomes. First, we analyzed the release of
exosomes from a murine keratinocyte cell line (MPEK) as well as their composition by multiple
approaches (ultracentrifugation, electron microscopy, western blot, and proteomics). Keratinocytes
produced exosomes under steady-state as well as different inflammatory conditions (+/- IFNγ). Fur-
ther, we examined the uptake of these exosomes by dendritic cells (BMDC) and their effects on
phenotypic and functional maturation. BMDCs showed a more mature phenotype indicated by a
significant increase of both CD40 positive cells and CD40 antigen expression as well as the pro-
duction of large amounts of IL6, 10, 12 after uptake of exosomes. Furthermore; we explored whether
exosomes were able to transfer antigen-specific information from keratinocytes over BMDCs to T
cells by inducing antigen-specific T cell stimulation of CD4 or CD8 T cells from OT-2 or OT-1 mice,
respectively. As shown by confocal microscopy, keratinocytes took up antigen (ovalbumin) which
was also present in exosomes as detected by western blot. However, exosomes failed to transfer
antigen to BMDCs in substantial amounts to induce antigen-specific T cell proliferation. Together,
these findings suggest that with this novel biological function keratinocytes are able to direct immune
responses under different inflammatory conditions by secreting differentially loaded exosomes.
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Complete B16 melanoma regression with Trp2-specific CTL expansion is elicited by intratu-
moral injections of a novel STAT3 inhibitor (rR9-GRIM19) plus Tc1/ Th1 inducers without
melanoma-specific immunotherapy
F Hanawa, N Shibagaki, T Okamoto and S Shimada. Department of Dermatology, University of
Yamanashi, Faculty of Medicine, Yamanashi, Japan
The cancer microenvironment severely limits the efficacy of various immunotherapies in part through
phosphorylated-STAT3 (pSTAT3). In culture, we confirmed that IL-6 and IL-10 secreted from B16
cells were the main STAT3-activators. Interestingly, pSTAT3 expression in all CD4+ and CD8+ T
cells of tumor-draining lymph nodes (DLNs) was elevated on day 5 after subcutaneous transplan-
tation of B16 cells. Although intratumoral (i.t.) injections of R9-protein transduction domain (PTD)-
containing GRIM19 (rR9-GRIM19); a novel STAT3 inhibitor, alone elicited anti-B16 effects, com-
plete B16 regression or IFN-gamma-producing T cells were not observed. Previously, we also have
demonstrated that i.t. immunization with R9-PTD-containing OVA fusion protein (rR9-OVA) elicited
anti-B16 melanoma effects with presenting OVA-epitopes (onto B16 cells) at injection area and with
OVA-specific Tc1/ Th1 immune responses. However, anti-B16 effects by rR9-OVA were severely
diminished when those immunization was started on and after day 5. To elicit complete B16 regres-
sion, we investigated the antitumor effects by various combined immunotherapies with rR9-GRIM19.
rR9-GRIM19 elicited the enhanced antitumor effects when combined either with CpG or rR9-OVA,
but only combination with CpG, rR9-OVA, plus rR9-GRIM19 (COG therapy) could elicit established
B16 regression with complete inhibition of pSTAT3 expression in CD4+/ CD8+ T cells of DLNs.
Interestingly, Trp2-specific rapid and strong CTL expansion with IFN-gamma-producing T cell phe-
notypes in DLNs was observed in COG-treated B16-bearing mice. COG therapy also elicited
strong memory effects by complete B16 rejection after rechallenge. These results indicate that B16-
specific CTL expansion and antitumor effects could be elicited without any specific immunothera-
pies when optimizing the cancer microenvironment. These results remind us the reconsideration of
current cancer immunotherapies.
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CD45+CD14+CD34-prenatal epidermal human leukocytes – Langerhans cell precursors?
C Schuster,1 C Vaculik,1 C Fiala,2 G Stingl,1 W Eppel3 and A Elbe-Bürger1 1 DIAID, Department
of Dermatology, Medical University of Vienna, Vienna, Austria, 2 Gynmed Ambulatorium,
Vienna, Austria and 3 Department of Gynaecology, Medical University of Vienna, Vienna,
Austria
Despite considerable efforts, the precise phenotype of the epidermal Langerhans cell (LC) precur-
sor has not yet been determined in humans. These elusive precursors migrate from early hematopoi-
etic sites into embryonic skin showing a primitive surface marker profile that subsequently matures
into the profile of adult LCs. Thus, clues about these precursors can be obtained by the study of
their ontogeny. Previously, CD36+HLA-DR+/- cells of unknown nature have been identified in the
embryonic epidermis. To further characterize their phenotype, the expression of selected markers
was evaluated on single cells and frozen sections of embryonic human skin. Using flow cytometry,
we found that 65.3% of CD45+ leukocytes exhibit the scavenger receptor CD36 at 9 weeks esti-
mated gestational age. Strikingly, significantly fewer CD45+CD36+ cells in embryonic skin express
HLA-DR compared to adult skin (38.4% vs. 98.3%, p=0.008). CD45+CD36+ cells are located pre-
dominantly in the dermis, where various subsets of CD36+ leukocytes can be identified with regard
to the expression of CD14 and HLA-DR. Of note, CD45+CD36+ cells are occasionally also observed
in the embryonic epidermis. While a subset of these epidermal leukocytes coexpresses CD14 and
HLA-DR, we also observed single CD45+ cells. Intriguingly, CD45+CD34+ cells, phenotypically
compatible with hematopoietic stem cells, are found rarely in first trimester dermis, frequently in
association with vessels, but not in the epidermis. Taken together, the study of leukocyte ontogeny
provides fascinating insights into the differentiation of epidermal LC. In analogy to what has been
found in various mouse models our data suggest that immature skin leukocytes acquire HLA-DR
during development in the skin. In addition, our finding that CD14+CD34- leukocytes are present
in the developing epidermis underscores the potential role which has been attributed to various
putative, already committed CD14+ LC precursors in adult skin.
009 
CB1 receptor deletion specifically on keratinocytes leads to enhanced IFNγ-dependent secre-
tion of proinflammatory chemokines and increased allergic contact hypersensitivity
E Gaffal,1 M Cron,1 N Glodde,1 T Bald,1 R Kuner,2 A Zimmer,3 B Lutz4 and T Tueting1 1 Dept. of
Dermatology and Allergology, University of Bonn, Bonn, Germany, 2 Institute for
Pharmacology, University of Heidelberg, Heidelberg, Germany, 3 Institute of Molecular
Psychiatry, University of Bonn, Bonn, Germany and 4 Institute of Physiological Chemistry,
University of Mainz, Mainz, Germany
Epidermal keratinocytes (KC) and cannabinoid (CB) receptors both participate in the regulation of
inflammatory responses in a mouse model for allergic contact dermatitis, the contact hypersensi-
tivity (CHS) response to the obligate sensitizer 2,4-dinitrofluorbenzene (DNFB). We investigated
the cellular and molecular mechanisms how CB1 receptors attenuate CHS responses to DNFB. For
this purpose we used a conditional gene targeting approach to identify the relative contribution of
CB1 receptors on epidermal keratinocytes for the control of CHS responses. To determine the under-
lying cellular and molecular mechanisms that regulate inflammatory responses in the effector phase
of CHS, we performed further investigations on inflamed ear tissue and primary keratinocyte cul-
tures using morphologic, molecular and immunologic methods. Mice with a keratinocyte-specific
deletion of CB1 receptors developed increased and prolonged CHS responses. These were associ-
ated with enhanced reactive epidermal acanthosis and inflammatory keratinocyte hyperprolifera-
tion in the effector phase of CHS. In vitro, primary cultures of CB1 receptor-deficient KC released
increased amounts of CXCL10 and CCL8 following stimulation with IFNγ compared to controls. In
vivo, contact allergic ear tissue of CB1 receptor-deficient keratinocytes show enhanced expression
of CXCL10 and CCL8 compared to controls. Further investigations establish CCL8 as a proinflam-
matory chemokine that participates in the regulation of the immune response in the effector phase
of CHS. Therefore we conclude that CB1 receptors are functionally expressed on keratinocytes in
vivo and help to balance the secretion of proinflammatory chemokines which regulate T-cell-depend-
ent inflammation in the effector phase of CHS.
010 
Pregnane X Receptor (PXR) modulates CCR7 and Langerhans cell migration via TGF-beta1
A Elentner,1 M Schmuth,1 M Hermann,2 F Gonzalez3 and S Dubrac1 1 Department of
Dermatology, Innsbruck Medical University, Innsbruck, Austria, 2 KTM-ZIT Laboratory,
Department of General and Transplant Surgery, Innsbruck, Austria and 3 Laboratory of
Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of
Health, Bethesda, MD
The pregnane X receptor (PXR) is a ligand-activated transcription factor regulating genes central to
drug and hormone metabolism in the liver. We here show that PXR is highly expressed in different
subsets of mouse and human immature DC especially Langerhans cells (LC) and is down-regulated
in mature DC. PXR ligands (PCN, pregnenolone, RU-486, hyperforin, dexamethasone-t-butyl-acetate)
down-regulate CCR7 expression at the cell surface of mouse LC without affecting expression of other
maturation markers such as CD40, CD86 and CXCR4 in vitro. In contrast, PXR antagonism by A-
792611 upregulates expression of CCR7 by LC. Pregnenolone and A-792611 exert superior PXR-
mediated effects than other ligands. Similarly, overexpression of the huPXR also called SXR together
with its down-stream gene CYP3A4 in mouse (Tg-SXRCYP3A4) decreases expression of CCR7 at the
cell surface of mouse LC, mimicking effects of pharmacological activation of PXR. In vivo, PXR
deficiency increases while transgenic expression of SXR decreases LC migration. Interestingly, Lan-
gerin+ cells lose PXR while migrating into skin tumors and PXR expression is lowered in intra-tumoral
CCR7+ cells in mice. Furthermore, PXR activation increases amounts of TGF-beta1 and SOCS-1 in
epidermal cells while PXR antagonism has opposite effects. Time course of TGF-beta1 and SOCS-
1 expression shows an early upregulation of TGF-beta1 (T2 hrs) and its well-kown target gene smad
3 (T4 hrs). All together these results demonstrate that PXR controls CCR7 and LC migration via TGF-
beta1.
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Possible roles of regulatory T cells in the development of atopic dermatitis-like Th2-dominant
cutaneous inflammation induced by repeated epicutaneous hapten application
S Hanakawa,1 A Kitoh,1 M Sugita,2 Y Miyachi1 and K Kabashima1 1 Department of Dermatology,
Graduate School of Medicine, Kyoto university, Kyoto, Japan and 2 Laboratory of Cell
Regulation, Institute for Virus Research, Kyoto university, Kyoto, Japan
Atopic dermatitis (AD) is characterized by cutaneous hyperreactivity to environmental triggers, which
is attributable to barrier dysfunction and Th2 predominance. Repeated topical application of hap-
tens to mouse skin is known to induce AD-like Th2 dominant cutaneous inflammation. However,
it remains unknown how repeated hapten challenges induce Th2-dominant inflammation, while
single hapten challenge results in IFN-γ-mediated Th1-type inflammation, i.e., contact hypersensi-
tivity. To this end, we first verified the detailed expression kinetics of various cytokines and chemokines
in the repeated hapten challenge model. Quantitative RT-PCR analysis of Th1-, Th2-, Th17-, and reg-
ulatory T (Treg)-associated genes revealed Th2 and Treg-dominant cutaneous cytokine milieu in
repeated hapten challenge-induced lesion, while single challenge-induced lesion was Th1-domi-
nant. In addition, the expression of AD-related genes, such as TARC, TSLP, IL-33, and IL-25, were
upregulated in repeated hapten challenge-induced lesion. Next we aimed to clarify the mechanism
how repeated hapten applications induce a Th2-skewed response. Initially, we observed that the
majority of T cells accumulated in the repeated hapten applied lesion are Treg cells. To evaluate
their role, we used Foxp3hCD2/hCD52 reporter mice, which allow selective depletion of Foxp3+ Treg
cells by injecting anti-hCD2 antibodies. We found that depletion of Treg cells prolonged Th1-type
immune responses, suggesting that Treg cells were involved in both the induction and the mainte-
nance of Th2-dominant responses in the model. Taken together, our results indicate that repeated
hapten challenges induce accumulation of CD4+Foxp3+ Treg cells into the inflammatory skin lesion,
which actively suppress Th1 immune response, resulting in Th2-skewed cutaneous inflammation.
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Distinct differentiation requirements and functional properties of microbe-specific human
TH17 cells
CE Zielinski,1 A Lanzavecchia,2 D Jarrossay,2 F Ronchi2 and F Sallusto2 1 Department of
Dermatology and Allergology, Charité Berlin, Berlin, Germany and 2 Cellular Immunology,
Institute for Research in Biomedicine, Bellinzona, Switzerland
Th17 cells have emerged as a new T helper cell lineage involved in the clearance of extracellular
bacteria and fungi. A dys-regulated Th17 response, however, can induce severe tissue destruction
and autoimmunity. Therefore, mechanisms must be in place to shield the host from immune-medi-
ated damage. We demonstrate that human Th17 cells transiently produce the anti-inflammatory
cytokine IL-10 upon stimulation. Interestingly, IL-10 expression was accompanied by reciprocal
down-regulation of IL-17, leading to a functional regulatory Th17 cell phenotype after the peak of
the effector response. The ability of Th17 cells to express IL-10 was, however, restricted to certain
antigen specificities. Ex vivo isolated C. albicans specific Th17 cells could not produce IL-10 in com-
parison to S. aureus specific Th17 cells. This was due to differential priming requirements of these
Th17 cell sub-populations. IL-1beta instructed naïve T cells to develop into a pro-inflammatory non-
IL10 expressing Th17 cell subset. Th17 cell priming with S. aureus, however, was not IL-1beta depend-
ent, leading instead to the generation of IL-10 producing Th17 cells with self-regulatory activities.
Thus, using a novel approach that combines the in vitro priming of naive T cells by whole microbes
with the ex vivo analysis of memory T cells we were able to unmask the existence of two types of
Th17 cells that differ in priming requirements, TCR repertoire and function. This approach revealed
that IL-1beta is a molecular switch for determining a memory for IL-10 expression. This has impor-
tant consequences for the physiological termination of pro-inflammatory immune responses and
the limitation of bystander damage in certain pathogen microenvironments. Targeting IL-1beta early
in the differentiation process of Th17 cells might therefore represent a promising therapeutic strat-
egy to confer anti-inflammatory properties to cellular mediators of autoimmune diseases.
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OX40L-expressing Dendritic cells promotes the auto-reactive CD8 response and dampen Treg
function un systemic lupus disease
C Contin-Bordes,1 C Jacquemin,1 J Seneschal,2 I Douchet,1 J Moreau,1 TS Kupper,3 S Muller4 and
P Blanco1 1 CIRID, CNRS UMR 5164, University of Bordeaux, Bordeaux, France, 2
Dermatology, INSERM U1035, University of Bordeaux, Bordeaux, France, 3 Dermatology,
Harvard Skin Disease Research Center, Boston, MA and 4 CNRS, UPR9021, IBMC, University
of Strasbourg, Strasbourg, France
Activation of effector CD8+ T lymphocytes, and dysfunction of regulatory T cells (Treg cells) play a
key role in autoimmune diseases notably in systemic lupus erythematosus (SLE). Activation of the
dendritic cell (DC) system has been suggested to be central in T cell dysfunction, yet the precise
mechanism remains incompletely understood. OX40L, a member of the tumor necrosis factor super-
family, primarily expressed on antigen presenting cells is a costimulatory molecule that plays a sen-
tinel role in the adaptive immune response. In SLE disease, we show that OX40L expression is
increased on blood and skin-infiltrating myeloid DCs from active patients in a CD40L dependent
manner, and correlates to disease activity. Moreover, OX40L-expressing DCs generated in vitro or
purified from active SLE patients promote the generation of activated cytotoxic effector CD8+ T cells
expressing HLA class II and granzyme. In lupus skin samples, These CD8+ T cells are found in close
relation with skin-infiltrating DCs. In additional experiments, OX40L-expressing DCs block the func-
tion of Treg cells through FoxP3 down-regulation. These data strongly suggest a crucial role for
OX40L/OX40 axis in SLE disease, promoting the auto-reactive immune response, while also inhibit-
ing the maintenance of tolerance. Finally, blocking OX40L in NZBxNZW(F1) lupus- prone mice
ameliorates overall survival and decreases disease activity. Those results establish the rationale for
proposing OX40L as a new therapeutic target in SLE disease.
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Contact dermatitis in psoriasis patients: a powerful model to analyze disease pathogenesis
S Eyerich,1 CB Schmidt-Weber,1 J Ring,2 A Cavani3 and K Eyerich2 1 Center of Allergy and
Environment (ZAUM), Technische Universität and Helmholtz Center, Munich, Germany, 2
Department of Dermatology and Allergy, Technische Universität, Munich, Germany and 3
Laboratory of Experimental Immunology, IDI-IRCCS, Rome, Italy
While allergic contact dermatitis (ACD) is an inflammatory skin disease limited to the area of direct
contact with allergens or small molecules, psoriasis is a systemic disease with keratinocytes react-
ing less to differentiating and apoptotic, but more to proliferative signals. It is unknown whether
contact dermatitis is altered under these conditions. Here, we induced ACD reactions against Der
p (atopy patch test, APT; n=2) and nickel (n=12) in sensitized psoriasis patients. Biopsies of acute
eczema reactions and active neighboring psoriasis plaques were investigated histologically, and T
cells isolated from lesional skin were phenotyped for cytokine secretion by ELISA and flow cytom-
etry as well as for specificity in co-culture with autologous dendritic cells. Clinically, all 14 patients
developed typical eczema upon antigen challenge. However, reaction was delayed compared to
non-psoriatic individuals, reaching its peak after 7-10 days. Histological analysis revealed typical
hallmarks for eczema in patch tests and for psoriasis in psoriasis lesions, respectively. T cells iso-
lated from APT reactions to Der p were mainly of the Th2 subset, while parallel obtained psoriatic
lesions were Th1/Th17 dominated. Interestingly, filaggrin expression was lower in APT reactions
than in psoriasis, confirming a suppressive role for Th2 cytokines on filaggrin synthesis. Also, Staphy-
lococci colonized APT, but not psoriasis lesions. That confirms opposing effects of different T cell
cytokines at innate immunity. In contrast to APT reactions, the T cellular infiltrate of ACD lesions to
nickel was comparable to the one of psoriasis with slightly more Th2 cells. In summary, we show
that psoriasis patients develop typical, but delayed contact dermatitis. Rather than genetically deter-
mined epithelial alterations, the eliciting antigen determines the pattern and clinical outcome of a
cutaneous T cell immune reaction.
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Impaired Langerhans’ Cell Migration in Aged Skin
S Ogden,1 RJ Dearman,2 I Kimber2 and CE Griffiths1 1 Dermatological Sciences, University of
Manchester, Manchester, United Kingdom and 2 Faculty of Life Sciences, University of
Manchester, Manchester, United Kingdom
Ageing is associated with an impaired cutaneous immune response resulting in an increased fre-
quency of skin infections and skin cancer. Epidermal Langerhans’ cells (LCs) are professional anti-
gen-presenting cells. They capture antigen, and migrate from the epidermis to draining lymph nodes
to initiate the T cell response. In order to migrate LCs require signals from interleukin (IL)-1β and
tumour necrosis factor (TNF)-α. Epidermal LC frequency is reduced in aged skin, and LC migration
in vivo is impaired following intradermal injection of TNF-α but not IL-1β. We investigated age-
related changes in LC function using sun-protected skin of healthy young (≤30 years) and old (≥70
years) individuals. To determine if ageing affects LC phenotype, which could indicate a reduced
propensity for migration, expression of markers of LC maturation (HLA-DR and CD86) was studied
using flow cytometry. There were no differences between age groups, furthermore there were no
differences in expression of the IL-1 receptor I, which is important in initiating LC migration. An
epidermal explant model was established to study LC migration ex vivo. Epidermal sheets taken
from 6mm punch biopsies were fixed immediately in acetone (T0) or floated on culture media for
24 hours (T24). The sheets were stained with CD1a and LC counts performed using fluorescence
microscopy. By comparing T0 and T24 LC counts the percentage of LCs that migrated from explants
was calculated. Spontaneous LC migration occurred from explants of all young individuals (mean
16.6+/-1.7%, n=12), whereas there was little or no migration from explants of old individuals (mean
2.1+/-0.8%, n=13). Addition of IL-1β to the culture media partially restored LC migration in the old
(mean 13.0+/-1.8%); TNF-α had no significant effect. The level of IL-1RA in the explant supernatant
was reduced in the old group. Taken together these data suggest that the age-related impairment in
LC function is related to changes in the epidermal microenvironment, in particular IL-1β signalling,
rather than changes in the LCs.
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Alterations in the regulatory T cell population in atopic-dermatitis-like cutaneous inflamma-
tion in mice
V Martinz,1 CH Tripp,1 D Finke,2 R Gruber,1 C Heufler-Tiefenthaler,1 M Schmuth1 and S Dubrac1
1 Department of Dermatology and Venereology, Innsbruck Medical University, Innsbruck,
Austria and 2 Developmental Immunology, Department of Biomedicine, University of Basel,
Basel, Switzerland
Although the important role of abnormal immune reactivity in the multifactorial pathogenesis of
atopic dermatitis (AD) is widely accepted, the complex network of the AD immune system remains
still unclear. Repeated high dose of topically applied vitamin D3 (VitD3) or overexpression of thymic
lymphopoietin (TSLP) under the K14 promotor result in Langerhans-cell-dependent AD-like inflam-
mation in mouse skin, characterized by epidermal hyperplasia, hyperkeratosis and dermal inflam-
mation. These symptoms are associated with enhanced mRNA expression of TSLP and other Th2
cytokines and chemokines in the skin and with elevated serum IgE levels. Mice with AD-like inflam-
mation show greater numbers of skin draining lymph node (sdLN) cells and increased numbers of
emigrated skin dendritic cells (DC) and regulatory T cells (Tregs). Proliferation of natural and induced
Tregs is similar in VitD3 treated mice but both populations are increased as compared to vehicle-
treated controls. Short-term topical application of VitD3, inducing acute AD-like inflammation,
upregulate Treg activation markers ICOS, CTLA-4 and GARP as well as IL-10 secretion by Tregs. In
K14-TSLP transgenic mice, a model of chronic AD-like skin inflammation, Tregs induce ICOS,
whereas production of IL-10 is not altered as compared to controls. Furthermore, AD-like inflam-
mation modulates expression of costimulatory molecules on various DC subsets in sdLN. Finally,
depletion of Langerin-expressing DC in Langerin-DTR (diphtheria toxin receptor) mice demonstrates
that a lack in Langerin+ DC promotes development of Tregs. While Tregs seem upregulated and acti-
vated in acute AD, defective regulatory function cannot be excluded in chronic AD as reported in
various cohorts of AD patients.
014
Induction of antigen specific IgE production upon epicutaneous sensitization with external
allergen is mediated by IL-17A
S Nakajima, Y Miyachi and K Kabashima Dermatology, Kyoto University Graduate School of
Medicine, Kyoto, Japan
Skin lesions of atopic dermatitis (AD) demonstrate an infiltration of T cells and increased expres-
sion of T helper 2 (Th2) cytokines in the acute stage. We previously reported that the number of IL-
17 positive cells is increased in peripheral blood and acute lesional skin of AD patients. These find-
ings suggest that IL-17A may play some roles in the development of AD; however the basis of IL-17A
in AD remains unknown. To evaluate the role of IL-17A, we use IL-17A deficient (IL-17A-/-) mice
and applied them to the repeated ovalbumin (OVA)- or hapten-induced epicutaneous sensitization
models. In both AD models, clinical manifestation was milder in IL-17-/- mice than WT mice, and
induction of antigen-specific IgE production was impaired in IL-17-/- mice compared with WT mice.
In addition, lesional skin of WT mice exhibited an elevated mRNA level of thymic stromal lym-
phopoietin (TSLP), a critical inducer of Th2 cytokine-associated inflammatory diseases; but induc-
tion of TSLP mRNA in IL-17-/- mice was attenuated. These results suggest that IL-17A promotes Th2
induction and stimulates antigen-specific IgE production. Next, to identify IL-17A producing cells
in the skin, we prepared epidermal suspensions from the lesional skin of WT mice after repeated
epicutaneous sensitization and analyzed by means of intracellular flow cytometry. We detected IL-
17A positive cells in epidermis, and these cells express γ4 chain with low to intermediate levels of
γδ T cell receptor. This result suggests that dermal γ4-positive γδT cells migrate and accumulate in
the epidermis, and then produce IL-17A upon epicutaneous sensitization. Taken together, our results
suggest that dermal γδT cells migrating into the epidermis are the essential sources of IL-17A in the
skin, and that IL-17A promotes Th2 induction and antigen-specific IgE production in the murine
AD models in line with TSLP induction in keratinocytes.
018
In situ Activation of Human Skin Resident T Regulatory Cells by Autologous Langerhans Cells
J Seneschal,2 R Clark,1 C Baecher-Allan1 and TS Kupper1 1 Dermatology, Harvard Skin Disease
Research Center, Boston, MA and 2 Dermatology, INSERM U1035, University of Bordeaux,
Bordeaux, France
Human skin contains abundant populations of resident memory T cells (TRM), including a popu-
lation of regulatory T cells (Treg). Human skin also contains diverse populations of dendritic cells
that can present antigen very efficiently to these TRM. It was previously demonstrated that in vitro,
autologous Langerhans Cells (LC), but not other DC, can induce proliferation in a subset of TRM,
and that these TRM are almost exclusively Treg, by both functional and phenotypic criteria. To deter-
mine whether this proliferation depended upon antigen presentation, we used blocking antibodies
to Class I and II MHC, as well as CD1. Only Class II blocking antibodies could inhibit LC induced
Treg proliferation. We further used blocking antibodies to HLA-DR, DP, and DQ, and found that the
inhibitory affect was mediated by HLA-DR. Finally, we asked whether we could see evidence for
LC activation of Treg in intact human skin. Using multicolor immunofluoresence, we were able to
show FoxP3+ T cells in apposition to CD1a LC in epidermis, and could show that a subset of these
T cells expressed the proliferation antigen Ki67. Taken together, these data suggest that in normal
uninflamed skin, LC may function to constitutively activate resident Treg, providing some insurance
against inadvertent or excessive activation of other TRM by commensal organisms or self antigens.
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T Cell Polarizing Capacity Of Myeloid Dendritic Cells In Atopic Dermatitis
G Nagy,1 D Minh,3 K Gáspár,1 G Mócsai,1 D Töröcsik,2 Z Bacsó,3 T Bíró,4 ÉVA Remenyik2 and
A Szegedi1 1 Department of Dermatology and Dermatological Allergology, University of
Debrecen, Medical and Health Science Centre, Debrecen, Hungary, 2 Department of
Dermatology, University of Debrecen, Medical and Health Science Centre, Debrecen,
Hungary, 3 Department of Biophysics and Cell Biology, University of Debrecen, Medical and
Health Science Centre, Debrecen, Hungary and 4 Department of Physiology, University of
Debrecen, Medical and Health Science Centre, Debrecen, Hungary
Our purpose was to examine whether isolated peripheral blood myeloid DCs (mDC) from severe
AD patients and from healthy controls differ in their cytokine expression profile de novo. Next we
also aimed to investigate how T cell polarizing capacity of mature mDCs will alter in AD patients
compared to healthy persons after stimulation by AD specific tissue microenvironment.
CD1c/BDCA1+ mDCs were isolated from peripheral blood of AD patients and healthy controls and
they were stimulated with Staphylococcus enterotoxin B (SEB) and thymic stromal lymphopoietin
(TSLP). After assessing the maturation status of mDCs, their intracellular cytokine production was
also measured using laser scanning cytometer. In the presence of SEB and TSLP, mDCs from AD
patients displayed significantly enhanced expression of maturation (CD83) and activation (CD86)
markers. In unstimulated conditions atopic mDCs had stronger ability to produce IL-2, CCL17, IL-
6 and TNF-α compared to controls and this alteration became statistically significant after stimula-
tion, except of CCL17. IL-12p40/p70 was not different initially in unstimulated mDCs from healthy
and atopic donors, however in the presence of SEB and TSLP the IL-12 producing capacity of
atopic mDCs significantly decreased compared to control mDCs. The expression of TGF-β, IL-10
and IL-23p19 showed only slight difference both in the unstimulated and in stimulated cells from
healthy and AD donors. According to our results, circulating atopic mDCs even in unstimulated
conditions have the capacity to prime AD characteristic Th2-Th22 responses tendentiously which
becomes statistically significant after stimulation.
020
Langerhans cells are required for imiquimod-induced psoriasiform skin inflammation in
mice
R Yoshiki,1 K Kabashima,2 H Yoshioka,1 R Hino1 and M Nakamura1 1 University of Occupational
and Environmental Health, Kitakyushu, Japan and 2 Kyoto University, Kyoto, Japan
Psoriasis is a common chronic inflammatory skin disease that involves dysregulated interplay between
immune cells and keratinocytes. Langerhans cells are a subset of dendritic cells that reside in the
epidermis and regulate immune responses. In contact hypersensitivity, the function of Langerhans
cells has been investigated extensively, however, their role in psoriasis remains to be clarified. We
assessed the role of Langerhans cells in a mouse model where psoriasiform skin inflammation is
triggered by a topical application of a TLR7/8 agonist, imiquimod. Langerhans cell-depletion by
utilizing diphtheria toxin (DT) in Langerin-DT receptor-knocked-in-mice suppressed hyperkerato-
sis, parakeratosis and neutrophil infiltration in the imiquimod-treated regions. In addition, deple-
tion of Langerhnas cells decreased the enhanced expression of STAT3 and Ki-67 in the epidermis
induced by imiquimod. Our data show that Langerhans cells are required for generation of psoria-
sis-like lesions by imiquimod in mouse models.
021
The dual (activating/suppressive) effect of extracellular HIV-1 Tat protein is driven by the
inflammatory microenvironment of infected lymphoid foci
H Le Buanec,1 T Sené,1 A Bensussan,1 M Bagot,2 R Gallo3 and D Zagury4 1 Université Paris
Diderot, Sorbonne Paris Cité, Laboratory of Immunology, Dermatology & Oncology, INSERM
UMR-S 976, Paris, France, 2 Service de dermatologie, Hopital Saint Louis, Paris, France, 3
Institute of Human Virology, University of Maryland Baltimore, Baltimore, MD and 4 Neovacs,
Paris, France
It has been shown that HIV-1 infects activated but not resting CD4+ T cells and that CPE induced
by viral replication together with the immunosuppressive effect triggered by extracellular Tat pro-
tein account for the decrease of CD4+ T cell count in infected patients. In lymphoid foci, depend-
ent on the level of viral infection, the stromal microenvironment surrounding immune cells could
include, together with extracellular Tat and circulating antiviral IFN-α, inflammatory innate factors
such as ATP and derivatives released by CPE-derived dead cells. We show that, according to its
concentration and the presence of inflammatory factors (IFN-α, ATP and ATP-derivatives), Tat pro-
tein may exert either an activation with enhanced production of IL2 or an immune suppression of
stimulated CD4+ T cells subpopulations. The double-edged sword of Tat activity on CD4+ T cells
could account for its immunopathogenic effects both at the early stage of infection (by allowing
CD4+ T cells activation and viral replication) and at late stages (by inducing immuosuppression,
source of opportunistic infections). Indications for targeting Tat protein by therapeutic vaccines in
subgroups of HIV-1 infected patients will be discussed .
022
Bet v 1-specific immune response in birch pollen allergic patients treated with sublingual
immunotherapy
C Möbs, K Ruge, M Hertl and W Pfützner Department of Dermatology and Allergology, Philipps
University Marburg, Marburg, Germany
For patients suffering from immediate type hypersensitivity allergen-specific immunotherapy (SIT)
provides an effective therapeutic strategy. In contrast to conventional SIT with allergen injections
administered subcutaneously, sublingual SIT (SLIT) is characterized by allergen delivery through the
mucosal route. Several studies have proven the clinical efficacy of SLIT, however, the underlying
immune mechanisms remain to be elucidated. In this study we analyzed allergen-specific T cellu-
lar and humoral immune responses in birch pollen (BP) allergic patients treated with SLIT over 3
consecutive birch pollen seasons. Bet v 1 (i.e. the major birch pollen allergen)-specific IL-5-, IFNγ-
and IL-10-producing T cells and CD4+CD25+CD127low/- regulatory T cells were determined by
means of ELISPOT analysis and flow cytometry, respectively. In addition, BP-specific IgE, IgA and
IgG antibody concentrations in peripheral blood were assessed by ImmunoCAP. While SLIT-treated
BP allergic patients experienced a clinical benefit, frequencies of Bet v 1-specific IL-5-secreting T
cells still peaked during BP seasons. However, IL-10-producing T cells were only increased during
the first 6 months of SLIT and percentages of CD4+CD25+CD127low/- regulatory T cells remained
unchanged over the whole observation period. In contrast, an increase of Bet v 1-specific IFNγ-pro-
ducing T cells was detected after the first year of SLIT, but the numbers declined to pre-treatment
levels after 24 months, suggesting other immunoregulatory mechanisms to be important during later
phases of SLIT. On the humoral level, BP-specific IgA and IgG(4) concentrations showed a constant
increase, starting after 3 and 6 months, respectively, while seasonally increased IgE synthesis ceased
to appear in the third treatment year. In summary, these findings suggest that SLIT-induced BP tol-
erance is the result of a dynamic interplay characterized by early alterations in allergen-specific T
cell numbers and long-term changes in specific antibody responses.
023
Inflammation-induced upregulation of adhesion molecules on endothelial cells is downreg-
ulated by Treg: Role of adenosine and cAMP
S Ring, A Enk and K Mahnke Ruprecht Karls University, Heidelberg, Germany
We have shown that in TNCB-induced contact hypersensitivity reactions regulatory T cell (Treg)
derived adenosine is able to block the expression of E- and P-selectin by inflamed endothelium,
leading to decreased T cell adhesion. As Treg generate adenosine by cleavage of ATP via CD39, we
started to analyze which cells produce ATP. In in vitro endothelial cell (EC)- Treg cocultures we found
that EC cells release ATP after activation, which subsequently activates Treg and enables them to
produce adenosine. To further determine which adenosine receptor is responsible for mediating
the effects on adhesion molecule expression by EC we cultured endothelial cells (EC) on glass
slides and superfused them with isolated, fluorescently labelled T cells. The adhesion of T cells to
the EC was quantified using videomicroscopy, and we show that conventional T cells (Tcon) strongly
adhered to TNF alpha activated EC. In contrast, addition of Treg prior to activation of the EC blocked
the adherence of Tcon significantly. This Treg-mediated blockage was abrogated by adding the A2A
adenosine receptor specific antagonist SCH58261 to the EC, whereas antagonists against A1, A2B
or A3 adenosine receptors did not affect Treg-mediated suppression. When analyzing the further
intracellular signalling events we recorded augmented cAMP levels and increased ERK1/2 phos-
phorylation in EC after Treg–EC cocultures. This signalling is typical for engagement of A2A recep-
tors. To verify the in vivo relevance of these findings, we further demonstrated expression of the
A2A adenosine receptors in CD31+ EC isolated from murine ears. Moreover, blocking of A2A recep-
tors in vivo prior to injection of Treg abrogated the immunosuppressive effect of Treg in the CHS
model. Therefore, we conclude that Treg mediated suppression via adenosine in the CHS model is
triggered by the A2A adenosine receptor, leading to elevated cAMP levels and ERK1/2 activation in
inflammatory stimulated endothelium.
024
Characterization of T-cell subsets and cytokine profiles in rejected skin grafts in an Epider-
molysis Bullosa model system
S Kitzmueller, M Ettinger, D Peckl-Schmid and JW Bauer Department of Dermatology, Division
of Molecular Dermatology and EB-House Austria, Paracelsus Medical University, Salzburg,
Austria
Patients suffering from genodermatoses often have null-mutations in genes encoding structural pro-
teins of the skin. In junctional Epidermolysis bullosa (JEB), patients lack type XVII collagen (hBPAG2)
in the dermo-epidermal basement membrane zone (BMZ). Replacing defective genes in the skin by
ex vivo gene therapy and subsequent transplantation of skin grafts is among the most promising
approaches for the treatment of Epidermolysis bullosa. This cutaneous genetherapy is complicated
by the risk of an immune response against the neo-antigen expressed in the skin graft. One critical
aspect for the success of this treatment is the induction and maintenance of tolerance towards this
neo-antigen. As a model system for this anti-graft response we use full-thickness skin from a trans-
genic mouse strain expressing hBPAG2 and graft it onto syngeneic wild-type C57BL/6 recipients.
We previously demonstrated tolerance induction towards hBPAG2 by in vivo delivery of its immun-
odominant domain, NC16A, via gene gun transfection. Graft acceptance was achieved in 80%.
Therefore the aim of the current study is the characterization of the immune response towards the
antigen in grafts of untreated recipients to be able to selectively block rejection of hBPAG2 express-
ing cells. Previous studies assume regulatory T-cells as master regulators of induced tolerance as in
vivo depletion of Tregs leads to rejection of transplanted as well as already accepted grafts. This
results should be verified by a compilation of rejection- or tolerance-associated cytokine profiles in
pre-treated, untreated and Treg-cell depleted mice. Furthermore the mode of action of gene gun
technology in mouse skin should be ascertained in closer detail.
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Expression of IL-1 family members in positive patch test reactions and upon hapten chal-
lenge in uninvolved skin of allergic contact dermatitis patients
A Balato, M Mattii, S Lembo, M Schiattarella, C Patruno, N Balato and F Ayala Department of
Dermatology, University of Naples Federico II, Napoli, Italy
The interleukin (IL)-1 family is a group of 11 members involved in immune regulation. The aim of
this study was to investigate the contribution of IL-1 family in allergic contact dermatitis (ACD). IL-
1 family members expression was quantified through qRT-PCR in positive patch test reaction site,
uninvolved skin of ACD patients and healthy skin. Moreover, ex vivo skin organ culture was per-
formed with uninvolved skin of ACD patients and healthy skin exposed to haptens and/or the irri-
tant SDS. Neutralization by antibody intradermal injection was performed for IL-1F11 whereas stim-
ulation assay with recombinant IL-1F5 in non-lesional ACD skin explants was executed. In addition,
expression of the antagonists IL-1F3 and IL-1F5 was quantified in primary lymphocytes isolated from
nickel allergic and non-allergic subjects, both stimulated with NiSO4. IL-1F2, IL-1F3, IL- 1F6, IL-
1F8 and IL-1F9 expression was enhanced in ACD lesional skin, whereas no IL-1F5 increase was
detected. Ex vivo skin cultures confirmed these results and showed that SDS did not affect all these
members expression. IL-1F11 was upregulated in vivo and ex vivo, either after challenge with aller-
gic or irritant compounds. Results were confirmed by immunohistochemical analysis. Reduction of
the inflammatory status was obtained by neutralizing IL-1F11, as shown by IL-8 and MCP-1 expres-
sion decrease, and by IL-1F5 recombinant treatment as supported by IL-1F6-9 and IL-8 downregu-
lation. Moreover NiSO4 was able to induce IL-1F3 in lymphocytes of nickel-allergic patients, whereas
no increase was detected for IL-1F5. In conclusion, we can assess that IL-1 family may be involved
in ACD pathogenesis. In particular, the absence of negative regulation by IL-1F5 might be respon-
sible for the increased proinflammatory activity of IL-1F6-9, whereas IL-1F11, resulting increased
either in allergic or irritant conditions, might function as an early warning system at sites of skin
damage.
027
Effects and mechanisms of citalopram treatment on murine contact allergic skin
H El-Nour and S Kiiskinen Department of Medicine Solna, Dermatology and Venereology
Unit, Karolinska Institutet, Stockholm, Sweden
The purpose of this study was to determine the effects and mechanisms of citalopram (a selective
serotonin reuptake inhibitor) treatment on murine allergic contact dermatitis (ACD) skin. Four groups
of 8 female Balb/c mice were used. Group A was a negative control whereas groups B, C and D
were induced to ACD. Citalopram was injected intraperitoneally to groups C (1 mg/kg) and D (2.5
mg/kg) while groups A and B were administered saline. Ear biopsies were fixed in 4% formalin with
0.2% picric acid. They were then stained using immunohistochemistry, a streptavidin-biotin tech-
nique, and antisera against serotonin (5-hydroxytryptamine, 5-HT), 5-HT1A and 5-HT2A receptors
(R), serotonin transporter protein (SERT), IL-6 and TNF-α. The samples were analysed using a floures-
cence microscope. Citalopram at 2.5 mg/kg exhibited anti-inflammatory effects on murine ACD. 5-
HT expression was seen on platelets, mast-like cells and nerve bundles in all the groups with no
recorded change in their expression among the inflamed groups. The numbers of 5-HT1AR and SERT
immunoreactive cells and nerve bundles as well as 5-HT2AR positive nerve bundles/fibres remained
un-altered in the inflamed groups. The number of IL-6 immunoreactive cells was lesser in group A
compared to B, C and D. IL-6 positive nerve bundles were incresed in numbers in groups B and C
compared to A. A higher number of TNF-α positive cells and a stronger immunoreactivity in the
epidermis was found in groups B, C and D in contrast to group A. The number of TNF-α positive
cells was decreased in group D compared to groups B and C. Citalopram might inhibit inflamma-
tion by a direct effect on immune cells rather than via the serotonergic system.
029
Therapeutic blockade of MALT1’s protease activity as a tool to block mature T cell prolifera-
tion in the skin
V Philippe1 and O Gaide2 1 Dermatology, Geneva University, Geneva, Switzerland and 2
Dermatology, Brigham and Women’s, Boston, MA
We have developed a new therapeutic tool that can block mature T cell proliferation in vitro and
in vivo (in mice). We based our strategy on the recent identification of the protease activity of MALT1,
a protein linking the T cell receptor with the transcription factor NF-kB, which we found to be essen-
tial for T cell proliferation. Using a small synthetic and cell permeable inhibitor of MALT1 activity,
we could block murine primary T cell proliferation induced by PMA-ionomycin, CD3-CD28 or anti-
genic stimulation. We could also show that activation of human T cell lines, human primary T cell
or leukemic T cells is strongly inhibited by this compound. Importantly, we confirm its therapeutic
potential in a mouse model, as we found that topical application of the MALT1 inhibitor prevents
the development of contact hypersensitivity. Taken together, our results identify the protease activ-
ity of MALT1 as a promising immunosuppressive target relevant to the fields of allergy, auto-immu-
nity and lymphoma.
028
Abrogation of human Langerhans’ cell migration by inhibition of β1 integrin function
FR Ali, RJ Dearman, S Ogden, KT Mellody, MJ Humphries, I Kimber and CE Griffiths University
of Manchester, Manchester, United Kingdom
Epidermal Langerhans’ cells (LCs) are the outermost sentinels of the immune system, charged with
maintaining immunological tolerance and translating novel antigenic stimuli into an appropriate
immune response. Following antigenic stimulation, LCs detach from surrounding keratinocytes and
migrate to local lymph nodes. Integrins are bidirectional signalling molecules involved in many
facets of cellular physiology, migration and survival. They exist as heterodimers, with α and β sub-
units. Functional α6 and α4 integrins with presumed β1 integrin partner subunits are required for
LC migration in mice. We have explored the role of β1 integrin in human LC migration using an
epidermal explant assay. Four 6mm punch biopsies were taken from sun-protected skin of 5 healthy
subjects (age 18-30y) and incubated in EDTA for 2h before the epidermis was removed. For each
subject, 1 epidermal sheet was fixed in acetone immediately (for baseline counts) and the remain-
ing 3 sheets cultured at 37C for 24h before fixation, in a RPMI medium containing rat anti-β1 inte-
grin monoclonal antibody, rat IgG2 isotype control antibody, or no antibody. The sheets were stained
with CD1a-FITC antibody before LC counts were performed using immunofluorescent microscopy.
Mean LC counts were 1186 +/- SD 139 per mm2 at baseline with a mean of 17% LCs migrating at
24h in the absence of antibody in the culture medium (mean LC count 983 +/- SD 85). There was
no significant difference in LC counts at 24h if isotype control antibody was added to the culture
medium (mean LC count 983 +/- SD 107; mean migration 18%). However, in the presence of anti-
β1 integrin antibody, the migration of LC was significantly reduced (p<0.05) or completely inhib-
ited (mean LC count 1184 +/- SD 117; mean migration -0.13%). These preliminary findings suggest
β1 integrin-containing heterodimers are involved in the migration of LCs from the epidermis. Future
investigations will seek to exploit the explant model to validate these findings and characterise fur-
ther integrin subunit involvement in LC mobilisation.
026
Tissue biomarkers in melanoma patients treated with TIL
A Knol,1 J Nguyen,4 M Pandolfino,3 G Quéreux,2 A Brocard,2 L Peuvrel,2 S Saiagh,3 A Khammari,2
N Labarrière1 and B Dréno2 1 CRCNA, Inserm U892, CRCNA, Inserm U892, Nantes, France, 2
Unité de Cancéro-Dermatologie, CIC biothérapie INSERM 0503, Nantes, France, 3 Unité de
Thérapie Cellulaire et Génique, CHU de Nantes, Nantes, France and 4 PIMESP-SEB, Hôpital
St Jacques, CHU de Nantes, Nantes, France
While treating stage III melanoma patients with autologous therapeutic TIL, we previously reported
that both progression-free survival and overall survival were significantly increased in the group of
patients with only one invaded lymph node. In this context, the main objective of the present study
was first to determine the difference in the characteristics of TIL expansions infused to the patients
between the group of patients bearing one invaded lymph node and the group of patients bearing
more than one invaded LN. The second objective was to determine if the tissue expression level of
several molecules involved in interactions between tumor cells and T cells was different between
the two groups, and thus to determine if they could be predictive markers of response to adoptive
immunotherapy using TIL. We confirmed that both PFS and OS were significantly associated to the
presence of tumor-reactive T-cells among TIL injected to the patients. Moreover, our results identi-
fied that 3 markers involved in interactions between melanoma cells and T cells have a significant
difference of expression between the 2 groups: MHC class I, adhesion molecule ICAM-1 and the
co-stimulation molecule LFA-3 whose expression was significantly weaker in tissue specimens from
patients with several invaded LN. In addition, the expression of the alpha chain of the IL-2 recep-
tor (CD25) and the nuclear transcription factor Foxp3 was significantly increased in LN tissue spec-
imens from the group of patients with several invaded LN. Our results suggest that the pattern of
the host tumor microenvironment may emerge as a general predictor of possible clinical benefit in
particular for treatment using TIL infusion.
030
A semi-automatic computational method to identify FOXP3+ T cell subpopulations in
melanoma patients
J Josse,1 H Fujii,2 F Husson1 and M Ono3 1 Laboratoire de mathématiques appliqués,
Agrocampus Ouest, Rennes, France, 2 Department of Dermatology, Kyoto University, Kyoto,
Japan and 3 Institute of Child Health, University College London, London, United Kingdom
Accumulating evidence indicates that FOXP3+CD4+ T cells do not comprise a homogenous regu-
latory population, but are composed of both regulatory T cells and non-regulatory effector T cells.
We have recently showed that both regulatory and non-regulatory FOXP3+ T cells are increased in
melanoma patients, and that regulatory T cells from these patients have an aberrant phenotype. As
is the case in almost all studies in immunology, in the previous study, we employed a manual gat-
ing approach by professional immunologists to identify FOXP3+ T cell subpopulations. It is, how-
ever, difficult to identify cellular populations simultaneously (not successively) using more than
two markers by manual gating. Thus, in order to understand more complex immunological profiles
based on multicolour flow cytometry data, we need to establish a data-oriented, computational
approach to identify immunologically distinct cellular populations and their phenotypes. Here we
report a data-oriented approach to identify FOXP3+ T cell subpopulations in a clinically meaning-
ful manner. We have established a new method using a model-based classification and k-means
clustering for identifying FOXP3+ T cell subpopulations. By statistically comparing the manual gat-
ing and the proposed method for identifying the characteristic dysregulations of FOXP3+ T cell sub-
populations in melanoma patients, we found that the proposed method was equivalent or superior
to the manual gating approach by immunological experts. Summarising, the proposed method pro-
vides an objective way to identify cellular populations by flow cytometry, and the identified popu-
lations may have more immunological and clinical relevance. In addition, this data-oriented method
to identify FOXP3+ T cell subpopulation is expected to have small between-centre variations, and
therefore to be used as a useful laboratory test for evaluating the immunological status of melanoma
patients.
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Alitretinoin – molecular and cellular mechanisms of action
A Kislat,1 S Meller,1 R Mota,1 PA Gerber,1 BA Buhren,1 E Bünemann,1 U Wiesner,1 T Ruzicka2 and
B Homey1 1 Department of Dermatology, Heinrich-Heine-University Hospital, Düsseldorf,
Germany and 2 Department of Dermatology, Ludwig-Maximilians-University, München,
Germany
Chronic hand eczema (CHE) represents an inflammatory skin disease with a high prevalence rang-
ing from 7-12% in Western industrialized countries. It was only starting from 2008 that the first,
and until now the only, systemic treatment option, i.e. oral alitretinoin was approved in several coun-
tries for severe CHE unresponsive to potent topical corticosteroids. However, as the precise mech-
anism of actions (MOA) of alitretinoin in CHE are so far unknown, we undertook following inves-
tigations in order to shed some light on potential underlying immunomodulatory mechanisms. To
investigate the mode of action of alitretinoin we stimulated human primary keratinocytes as well as
leukocyte subsets and performed quantitative real-time PCR analyses, FACS-analyses, cell-prolifer-
ation assays as well as mixed leukocyte reactions (MLR). Alitretinoin acts on keratinocytes as well
as dendritic cells. Keratinocytes show a significant reduction of chemokine expression after stimu-
lation with alitretinoin whereas on dendritic cells alitretinoin inhibits the upregulation of the mat-
uration marker CD83 as well as the co-stimulatory molecules CD80 and CD86. Consequently,
alitretinoin-treated dendritic cells show significantly impaired T cell activating properties. Further
analyses demonstrated that the immunomodulatory effect of alitretinoin results in a marked sup-
pression of allogenic proliferation of leukocytes in MLR. Taken together, these results suggest that
alitretinoin modulates innate as well as adaptive immune responses by suppression of chemokine-
induced leukocyte recruitment and inhibition of dendritic cell-mediated T cell activation.
032
Evaluation of the correlation between regulatory T and plasmacytoid dendritic cells with grad-
ing of squamous cell carcinoma
E Zavattaro,1 B Azzimonti,3 M Provasi,1 G Valente,2 A Conca,2 L Rimondini4 and E Colombo1 1
Azienda Ospedaliero-Universitaria Maggiore della Carità, Dermatology Unit, Novara, Italy, 2
Azienda Ospedaliero-Universitaria Maggiore della Carità, Pathology Unit, Novara, Italy, 3
University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy and 4
University of Piemonte Orientale, Science of Health, Novara, Italy
Regulatory T (Treg) and plasmacytoid dendritic cells (pDC) play a role in tumour immunity response.
Indeed, Treg are involved in the process of self-tolerance, but they simultaneously might permit the
development of neoplasms. On the other hand, pDC are implicated in both acquired and innate
immunity, specifically against viral infections. However, the relationship between T reg, pDC pop-
ulations in the presence of viruses and patient prognosis remains controversial. The current study
aims to establish a correlation between inflammatory infiltrate markers and cutaneous squamous
cell carcinoma (SCC) grading and determine the predictive value of T reg and pDC cell density in
a cohort of SCC by using an immunohistochemical assessment. Forty SCC patients, twenty G1 (14
males and 6 females, mean age 79 years) and twenty G3 (12 males and 8 females, mean age 83
years) referring to the local Dermatology Unit, have been recruited and subjected to double immuno-
histochemistry for CD25/FOXP3 (Treg cells) and single staining for CD303 (pDC) and also for CD4
and CD8. The total number of FOXP3/CD25 Treg cells significantly correlated with the grading of
the neoplasia and higher tumour grade. Since many studies indicate the involvement of β-HPV in
skin carcinogenesis, the presence of these viruses will be also evaluated and correlated with pDC
expression as these cells are well known producers of antiviral type I IFN and modulators of T cell
response.
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Th17 cells in nummular dermatitis: an immunohystochemical and clinical study
L Bianchi, V Bellini, S Pelliccia and P Lisi Clinical, Allergological, and Venereological
Dermatology Unit, University of Perugia, Perugia, Italy
T-helper (Th)17 cells are a Th lymphocytes subset characterized by a specific cytokine profile. IL6
and TGFβ induce the differentiation of naive T cells into Th17; IL23 allows the amplification of the
cell clone and elaboration of pro-inflammatory cytokines (IL17, IL22). Th17 cells are involved in
the pathogenesis of some cutaneous diseases. Among eczematous dermatitis, atopic and allergic
contact dermatitis have been investigated. The aim of this study was to explore a possible role of
Th17 cells in nummular dermatitis (ND). A panel of cytokines (TGFβ, IL6, IL17, IL22, IL23) was used
for studying the Th17 cells in serum (ELISA) and in skin (immunohystochemistry) of 25 ND patients
and 25 healthy subjects. In all enrolled subjects medical history, physical examination, blood analy-
sis, nasal, pharyngeal, and cutaneous swabs, panoramic x-ray radiography, prick tests, and patch
tests (SIDAPA standard series) were carried out. Statistical analysis was performed with Mann-
Whitney, Pearson Chi-Square and Spearman’s tests. The mean number of IL17+ cells per high-power
field in ND skin was higher than in healthy skin (1.8 ± 2.4 vs 0.5 ± 0.4 in the epidermis; 7.4 ± 10.6
vs 2.8 ± 1.6 in the dermis). In ND patients, the IL17 expression was significantly correlated (rho<0.05)
to IL6. This allowed us to divide ND patients in two groups: in the first, characterized by increased
IL17 and IL6 cutaneous expression, the swabs revealed a higher Staphylococcus (S.) aureus colo-
nization [70.0% vs 33.3% in the nose; 80.0% vs 16.7% (p<0.05) in the skin] than in the second,
in which the IL6 and IL17 expression was similar to that of the healthy skin. Moreover, the increased
expression was correlated with length of the disease (24.6 ± 28.7 months in the first group vs 4.3 ±
3.6 in the second; p<0.01), but not with sex, age, clinical features, atopy, and contact sensitivity.
Our results suggest that Th17 cytokines, especially IL17 and IL6, play a role in the pathogenesis of
ND, when the disease is associated with skin S. aureus colonization and/or it is in the subacute
phase.
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